Roche Gets US FDA Clearance for Test Detecting Vaginal Infections

10:47 AM EDT, 07/24/2026 (MT Newswires) -- Roche Holding (RO.SW) received a 510(k) clearance from the US Food and Drug Administration for its molecular diagnostic test cobas, according to a Friday release. The Swiss drugmaker's cobas test detects Bacterial vaginosis and Candida vaginitis from a single vaginal swab sample and is intended for professional laboratory use.